The ROE as of December 2025 (TTM) for Alto Neuroscience, Inc. (ANRO) is -44.81%

According to Alto Neuroscience, Inc.’s latest financial reports and current stock price. The company's current ROE is -44.81%. This represents a change of 294.27% compared to the average of -11.36% of the last 4 quarters.

Alto Neuroscience, Inc. (ANRO) Historical ROE (quarterly & annually)

How has ANRO ROE performed in the past?

The mean historical ROE of Alto Neuroscience, Inc. over the last ten years is 38.97%. The current -44.81% ROE has changed -214.98% with respect to the historical average. Over the past ten years (40 quarters), ANRO's ROE was at its highest in in the December 2022 quarter at 19.92%. The ROE was at its lowest in in the March 2023 quarter at -20.40%.

Alto Neuroscience, Inc. (ANRO) ROE by Quarter and Year

Discovering the peaks and valleys of Alto Neuroscience, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alto Neuroscience, Inc. (ANRO) Average ROE

How has ANRO ROE performed in the past?

The current ROE of Alto Neuroscience, Inc. (ANRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alto Neuroscience, Inc. (ANRO) ROE vs. Peers

How is ANRO’s ROE compared to its peers?

Alto Neuroscience, Inc.’s ROE is greater than Cellectis S.A. (-49.81%), greater than AC Immune S.A. (-49.04%), greater than Amarin Corporation plc (-18.34%), greater than Larimar Therapeutics, Inc. (-62.92%), greater than Contineum Therapeutics, Inc. Class A Common Stock (-32.33%), greater than Aldeyra Therapeutics, Inc. (-73.63%), greater than Alpha Tau Medical Ltd. (-56.45%), greater than Silence Therapeutics plc (-85.88%), greater than Korro Bio, Inc. (-61.51%), greater than DBV Technologies S.A. (-287.15%),

Build a custom stock screener for Alto Neuroscience, Inc. (ANRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alto Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alto Neuroscience, Inc. (ANRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alto Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.